Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance
- PMID: 37337409
- DOI: 10.1002/cncr.34896
Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance
Keywords: VHL; endolymphatic sac tumors; hemangioblastomas; kidney cancer; pancreatic neuroendocrine tumors; pheochromocytoma; renal cell cancer; von Hipple-Lindau syndrome.
References
REFERENCES
-
- Nielsen SM, Rhodes L, Blanco I, et al. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol. 2016;34(18):2172-2181. doi:10.1200/JCO.2015.65.6140
-
- Lonser RR, Glenn GM, Walther M, et al. Von Hippel-Lindau disease. Lancet. 2003;361(9374):2059-2067. doi:10.1016/S0140-6736(03)13643-4
-
- Maher ER, Neumann HPH, Richard S. Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19(6):617-623. doi:10.1038/EJHG.2010.175
-
- Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel-Lindau (VHL) gene: its role in renal cancer. JAMA. 1995;273(7):564-570. doi:10.1001/jama.273.7.564
-
- Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 2015;15(1):55-64. doi:10.1038/nrc3844
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
